Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $17,008 - $19,652
-449 Reduced 6.56%
6,391 $273,000
Q4 2023

Feb 08, 2024

SELL
$31.71 - $38.95 $19,026 - $23,370
-600 Reduced 8.06%
6,840 $264,000
Q3 2023

Nov 08, 2023

BUY
$37.32 - $49.29 $1,455 - $1,922
39 Added 0.53%
7,440 $280,000
Q2 2023

Aug 08, 2023

BUY
$39.98 - $47.68 $39 - $47
1 Added 0.01%
7,401 $337,000
Q4 2022

Feb 13, 2023

SELL
$49.7 - $57.71 $12,226 - $14,196
-246 Reduced 3.22%
7,400 $377,000
Q3 2022

Nov 03, 2022

SELL
$53.86 - $66.8 $8,240 - $10,220
-153 Reduced 1.96%
7,646 $412,000
Q2 2022

Aug 02, 2022

SELL
$63.83 - $80.0 $29,744 - $37,280
-466 Reduced 5.64%
7,799 $501,000
Q1 2022

May 16, 2022

BUY
$76.85 - $89.45 $74,160 - $86,319
965 Added 13.22%
8,265 $641,000
Q1 2022

May 06, 2022

SELL
$76.85 - $89.45 $74,160 - $86,319
-965 Reduced 11.68%
7,300 $566,000
Q4 2021

Jun 02, 2022

BUY
$74.57 - $87.19 $71,960 - $84,138
965 Added 13.22%
8,265 $710,000
Q4 2021

Feb 03, 2022

SELL
$74.57 - $87.19 $86,202 - $100,791
-1,156 Reduced 13.67%
7,300 $627,000
Q3 2021

Jun 02, 2022

BUY
$73.77 - $83.61 $85,942 - $97,405
1,165 Added 15.98%
8,456 $680,000
Q3 2021

Nov 03, 2021

BUY
$73.77 - $83.61 $333,883 - $378,418
4,526 Added 163.69%
7,291 $586,000
Q2 2021

Jun 02, 2022

BUY
$80.5 - $88.01 $8,050 - $8,801
100 Added 3.75%
2,765 $222,000
Q2 2021

Aug 16, 2021

SELL
$80.5 - $88.01 $7,969 - $8,712
-99 Reduced 3.58%
2,665 $214,000
Q1 2021

Jun 02, 2022

BUY
$76.38 - $86.03 $7,638 - $8,603
100 Added 3.75%
2,764 $233,000
Q1 2021

May 11, 2021

BUY
$76.38 - $86.03 $203,476 - $229,183
2,664 New
2,664 $225,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Sheaff Brock Investment Advisors, LLC Portfolio

Follow Sheaff Brock Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheaff Brock Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sheaff Brock Investment Advisors, LLC with notifications on news.